Recent advances on drug delivery nanoplatforms for the treatment of autoimmune inflammatory diseases DOI Creative Commons
Jing Zhu, Weihong Chen, Yuansong Sun

et al.

Materials Advances, Journal Year: 2022, Volume and Issue: 3(21), P. 7687 - 7708

Published: Jan. 1, 2022

As one of the current research hotspots, drug release nanoplatforms have great potential in treatment autoimmune inflammatory diseases.

Language: Английский

Interactions between Nanoparticles and Intestine DOI Open Access
Manuela Vitulo, Elisa Gnodi, Raffaella Meneveri

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(8), P. 4339 - 4339

Published: April 14, 2022

The use of nanoparticles (NPs) has surely grown in recent years due to their versatility, with a spectrum applications that range from nanomedicine the food industry. Recent research focuses on development NPs for oral administration route rather than intravenous one, placing interactions between and intestine at centre attention. This allows functionalization exploit different characteristics digestive tract, such as pH, intestinal mucus layer, or absorption capacity. On other hand, these same can represent problem complexity, also considering potential matrix microbiota. review intends give comprehensive look into three main branches delivery through route: drug carriers systemic targets, case insulin an example; drugs locally active intestine, treatment inflammatory bowel diseases colon cancer; finally, concerns side effects accidental uncontrolled exposure employed additives, focus E171 (titanium dioxide) E174 (silver NPs).

Language: Английский

Citations

62

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease DOI
Defeng Li, Meifeng Yang, Haoming Xu

et al.

Journal of Materials Chemistry B, Journal Year: 2022, Volume and Issue: 10(31), P. 5853 - 5872

Published: Jan. 1, 2022

As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation.

Language: Английский

Citations

59

Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment DOI
Naijing Ye, Peng Zhao,

Shibu Ayue

et al.

International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 232, P. 123229 - 123229

Published: Jan. 13, 2023

Language: Английский

Citations

33

Biodegradable Biopolymeric Nanoparticles for Biomedical Applications-Challenges and Future Outlook DOI Open Access

Radhakrishnan Sreena,

A. Joseph Nathanael

Materials, Journal Year: 2023, Volume and Issue: 16(6), P. 2364 - 2364

Published: March 15, 2023

Biopolymers are polymers obtained from either renewable or non-renewable sources and the most suitable candidate for tailor-made nanoparticles owing to their biocompatibility, biodegradability, low toxicity immunogenicity. Biopolymeric (BPn) can be classified as natural (polysaccharide protein based) synthetic on basis of origin. They have been gaining wide interest in biomedical applications such tissue engineering, drug delivery, imaging cancer therapy. BPn synthesized by various fabrication strategies emulsification, ionic gelation, nanoprecipitation, electrospray drying so on. The main aim review is understand use biodegradable biopolymers applications. There very few reviews highlighting biopolymeric employed medical applications; this an attempt explore possibilities using these materials This highlights based (albumin, gelatin, collagen, silk fibroin); polysaccharide (chitosan, starch, alginate, dextran) (Poly lactic acid, Poly vinyl alcohol, caprolactone) that has recently used many different also being highlighted. future perspective challenges faced employing reviewed.

Language: Английский

Citations

30

Drug Delivery of Gelatin Nanoparticles as a Biodegradable Polymer for the Treatment of Infectious Diseases: Perspectives and Challenges DOI Open Access
Osama A. Madkhali

Polymers, Journal Year: 2023, Volume and Issue: 15(21), P. 4327 - 4327

Published: Nov. 5, 2023

In recent years, there has been a growing interest in the use of gelatin nanoparticles (GNPs) for treatment infectious diseases. The inherent properties these make them attractive options drug delivery. Their biocompatibility ensures that they can interact with biological systems without causing adverse reactions, while their biodegradability break down harmlessly body once function is performed. Furthermore, capacity controlled release therapeutic agents be delivered over sustained period, thereby enhancing efficacy. This review examines current landscape GNP-based delivery, specific focus on its potential applications and challenges context Key include controlling rates, ensuring nanoparticle stability under physiological conditions, scaling up production maintaining quality, mitigating immunogenic optimizing loading efficiency, tracking biodistribution clearance GNPs body. Despite hurdles, hold promising realm disease treatment. Ongoing research innovation are essential to overcome obstacles completely harness clinical applications.

Language: Английский

Citations

27

Bioresponsive nanotechnology in pediatric dental drug delivery DOI Creative Commons
Seyed Ebrahim Alavi, Lieba Malik, Raghad Matti

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 93, P. 105436 - 105436

Published: Feb. 1, 2024

Nanotechnology in the field of pediatric dentistry offers innovative solutions to challenges. In this literature review, nanomaterials application dentistry, addressing critical concerns, such as toxicity and regulatory hurdles, is discussed. Also, unique physicochemical properties nanomaterials, including size, biocompatibility, drug delivery capabilities are explored. The safety efficacy nanoscale therapeutics were found be before their use dentistry. Polymer-based systems, especially those using natural polysaccharides, demonstrate great potential prevalent dental issues children. These systems can perform targeted therapy, reduce dosages, minimize side effects, making them beneficial for addition, future personalized treatments While advantages applying nanotechnology readily apparent, ongoing research should performed maximize its address

Language: Английский

Citations

13

Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome DOI

Yubiao Huang,

Jiaqi Xu,

Ge Sun

et al.

Biomaterials, Journal Year: 2024, Volume and Issue: 314, P. 122822 - 122822

Published: Sept. 12, 2024

Language: Английский

Citations

9

Colon-targeted dual-coating MOF nanoparticles for the delivery of curcumin with anti-inflammatory properties in the treatment of ulcerative colitis DOI

Haoqiang Lei,

Yipeng Liu, Jing Li

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 250, P. 114545 - 114545

Published: Feb. 1, 2025

Language: Английский

Citations

1

Multifunctional chrysin-loaded gallic acid–glycerol monostearate conjugate-based injectable hydrogel for targeted inhibition of hypoxia-induced NLRP3 inflammasome in ulcerative colitis DOI
Ajay Kumar,

Rahul Sakla,

Kanika

et al.

Biomaterials Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon part of large intestine.

Language: Английский

Citations

1

Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis: A combinational therapeutic approach DOI
Md. Meraj Ansari, Anas Ahmad, Ajay Kumar

et al.

Carbohydrate Polymers, Journal Year: 2021, Volume and Issue: 258, P. 117600 - 117600

Published: Jan. 13, 2021

Language: Английский

Citations

56